Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine

NCT02545075

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Nanjing, Jiangsu, China

Local Institution Changchun, Jilin, China

Local Institution Xi’an, Shanxi, China

Local Institution Tianjin, Tianjin Municipality, China

View Trial Details

Completed

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002)

NCT01704287

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +11 more
Locations: Not specified

View Trial Details

Completed

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

NCT00066404

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +114 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations: Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States

Mayo Clinic - Arizona Scottsdale, Arizona, United States

University of Arizona Cancer Center Tucson, Arizona, United States

University of Iowa Iowa City, Iowa, United States

View Trial Details

Completed

Spanish Registry of Mohs Surgery

NCT02310503

Conditions: Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +24 more
Locations: Hospital Universitario de Cruces Barakaldo, Spain

Hospital del Mar Barcelona, Spain

Hospital Quirón Teknon Barcelona, Spain

Hospital Santa Creu i Sant Pau Barcelona, Spain

View all 15 locations

View Trial Details

Completed

A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors

NCT02516527

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Guangzhou, Guangdong, China

View Trial Details

Completed

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

NCT02431572

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +21 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

NCT01916135

Conditions: Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

NCT02285101

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: California Cancer Associates for Research and Excellence, cCARE San Diego, California, United States

John Wayne Cancer Institute Santa Monica, California, United States

View Trial Details

Completed

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

NCT03002376

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Radboud University Medical Center Nijmegen, Netherlands

Military Medical Academy Belgrade, Serbia

Seoul National University Hospital Seoul, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Melanoma

Melanoma trial results

Related conditions